Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2754 results

Press release / Sep 24, 2025

New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after…
Research disease areas
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Clinical Trials / Jun 02, 2025

Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation
Clinical Trials / Jul 03, 2025

Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation
Clinical Trials / Mar 10, 2025

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
Clinical Trials / Jan 14, 2025

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis
Clinical Trials / Sep 16, 2025

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)
Expected currency impact
Novartis financial data

‹ Previous page
1
…
17
18
19
20
21
22
23
…
276
› Next page